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A new mechanism of autoimmune 
nephritis
Systemic lupus erythematosus (SLE) and other autoimmune dis-
eases are thought to be due to aberrant responses of the adaptive 
immune system to self-antigens. Nonetheless, the molecular and 
cellular mechanisms that trigger the initiation and determine the 
progression of autoimmune diseases are still poorly understood.
In a recent communication, Green et al. describe an SLE-like 
disease in mice lacking the enzyme α-mannosidase II (αM-II) that 
appears to be independent of adaptive immunity. These mice have 
normal kidney development, but when they are old they develop 
typical symptoms of SLE and lupus nephritis, including high titers 
of anti-DNA antibody, immunoglobulin deposition in the kidneys, 
and renal failure. The αM-II enzyme is involved in the biosynthe-
sis of N-linked glycans of glycoproteins, and its absence leads to 
generation of simple N-glycans instead of the complex branched 
N-glycans found in cell-surface glycoproteins of vertebrates.
To examine the role of antibodies and adaptive immunity in 
development of the disease, mice lacking αM-II were crossed with 
mice lacking recombinase-activating gene-1 that are deﬁcient in 
production of T and B cells. Remarkably, absence of an adaptive 
immune system worsened the SLE-like disease, demonstrating 
that initiation and progression of the disease did not require an 
immune response to self-antigen. Mesangial cells of mice lacking 
αM-II produced monocyte chemoattractant protein-1 (MCP-1) 
(Figure), which recruits and activates macrophages. Green et al. 
tested the response of mesangial cells to a variety of mannose-con-
taining glycans, as these cells contain lectin receptors that recognize 
the mannose epitopes present in lower eukaryotes. They found that 
MCP-1 production was induced on exposure of mesangial cells to 
yeast cell-wall mannan and, remarkably, to serum from αM-II-deﬁ-
cient mice. Thus, it appears that in mice lacking αM-II, some cells 
release glycoproteins carrying simple N-glycans that accumulate in 
organs such as the kidneys. There they are recognized as non-self 
by mannose-binding lectins of the innate immune system, leading 
to an inﬂammatory response resulting from MCP-1 production 
and macrophage inﬁltration and activation as well as autoantibody 
formation. Although the ﬁnding of anti-DNA antibodies in serum 
of αM-II null mice initially led to the conclusion that their SLE-
like disease was due to an aberrant adaptive immune response to 
self-antigens, it appears that this response is secondary to another 
primary disease mechanism. (Immunity 2007; 27: 308–320) 
Juan Oliver
Renal parvalbumin regulates 
the thiazide-sensitive Na+-Cl– 
cotransporter
Parvalbumin (PV) is a cytosolic Ca2+-binding protein expressed 
in the distal convoluted tubule (DCT), where its role remains 
unknown. It belongs to the superfamily of EF-hand Ca2+-binding 
proteins that play many roles in cellular processes. Parvalbumin 
contains a pair of functional EF-hand motifs that bind two Ca2+ 
ions with high aﬃnity. It is found in abundance in fast-contracting 
muscles, as well as in some neurons. Generation of parvalbumin 
knockout (Pvalb–/–) mice conﬁrmed the important role played by 
this protein in muscle and brain; the fast muscles of Pvalb–/– mice 
had decreased relaxation, and the animals had increased suscepti-
bility to epileptic seizures.
The selective renal distribution of PV in the early part of the DCT 
as well as its Ca2+-buﬀering properties raise the question of whether 
it plays a role in the transport systems operating in this nephron 
segment. The DCT reabsorbs ≈5% of the ﬁltered load of Na+, a 
process that involves the thiazide-sensitive Na+-Cl– cotransporter 
(NCC) and the ClC-Kb chloride channel, located on the apical and 
basolateral membrane of the cells, respectively. The DCT also is 
involved in Ca2+ and Mg2+ reabsorption. To explore the potential 
role of parvalbumin in these transport processes, Belge et al. used 
Pvalb–/– mice and examined the renal handling of NaCl and diva-
lent cations in basal conditions and after acute administration of 
diuretics and NaCl repletion.
Mesangial cell activation. RCA-1 (ricinis communis agglutinin-1) lectin 
binding in the glomerulus marks mesangial cells, which express MCP-1 in 
mice lacking αM-II.
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Staining for parvalbumin (green) and the sodium chloride cotransporter 
NCC (red) in mouse kidney cortex. The cytosolic Ca²+-binding protein 
parvalbumin colocalizes with NCC in the early distal convoluted tubule. 
Scale bar, 100 μm.
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They found that PV colocalized with the NCC in the early DCT 
(Figure) and that the Pvalb–/– mice showed increased diuresis and 
kaliuresis at baseline with higher aldosterone levels than Pvalb+/+ 
mice. Acute furosemide administration increased diuresis, natriu-
resis, and kaliuresis, but, surprisingly, did not induce calciuria in 
Pvalb–/–. However, after NaCl repletion, the mice had a rise in cal-
ciuria both at baseline and after furosemide, suggesting that volume 
depletion caused compensatory NaCl and Ca2+ reabsorption in the 
proximal tubule. Of great interest, Pvalb–/– mice showed no diuretic 
response to hydrochlorothiazide and a reduced expression of NCC 
in the early DCT. Studies in mouse DCT cells showed that NCC 
expression is Ca2+ dependent and can be modulated by the levels of 
PV. These results indicate that PV regulates the expression of NCC 
by modulating intracellular Ca2+ signaling in DCT cells. (Proc Natl 
Acad Sci USA 2007; 104: 14849–14854)
Juan Oliver
Autocrine VEGF signaling required 
for endothelial homeostasis
During development, vascular endothelial growth factor (VEGF) 
is critical for the diﬀerentiation of endothelial cells and morpho-
genesis of the vascular system. In the adult, VEGF is required 
for pathologic growth of vessels in many conditions, including 
ischemia, inﬂammation, retinopathies, and arthritis. VEGF acts 
through two high-aﬃnity receptor tyrosine kinases, VEGFR1/ﬂt-1 
and VEGFR2/KDR/ﬂk-1; both are expressed on normal vascular 
endothelial cells. VEGFR2 is thought to mediate most of the angio-
genic functions attributed to VEGF, whereas the role of VEGFR1 
signaling is less clear.
While the pro-angiogenic eﬀects of VEGF are clear, VEGF was 
originally discovered for its ability to increase vascular permeabil-
ity and has been shown to be needed to maintain the diﬀerenti-
ated phenotype in fenestrated endothelia of pancreatic islands and 
glomeruli. The function of VEGF in nonpathologic adult tissues 
remains largely unknown. To investigate the role of endothelial-
derived VEGF in the adult, Lee et al. generated mice with genetic 
deletion of vegf speciﬁcally in the endothelial lineage (Figure). 
When adult, these animals showed hemorrhages, multiple micro-
infarcts, and intestinal perforations; examination of endothelial 
cells revealed typical changes associated with apoptotic cell death. 
The vascular abnormalities resulted in cardiac dysfunction and 
increased sudden death. Remarkably, this phenotype manifested 
without detectable changes in the total levels of VEGF mRNA or 
protein, indicating that paracrine VEGF could not compensate for 
the absence of endothelial VEGF. This elegant study shows that in 
vivo autocrine VEGF signaling is required for endothelial cell sur-
vival under nonpathologic conditions and in a cell-autonomous 
manner. (Cell 2007; 130: 691–703) 
Juan Oliver
Antihypertensive action of the 
prostaglandin E2 receptor subtype 1
Prostaglandins participate in arterial blood pressure and renal salt 
excretion regulation. Their predominant eﬀect is to reduce blood 
pressure, consistent with clinical observations that inhibitors of 
prostaglandin synthase cause hypertension. More recently, diver-
gent cardiovascular eﬀects of COX1 versus COX2 inhibition have 
been observed; selective COX1 inhibition or COX1 gene knockout 
reduced and COX2 inhibition enhanced the pressor eﬀect of angio-
tensin II. The speciﬁc prostaglandins responsible for these divergent 
eﬀects of COX products remain poorly deﬁned.
Endogenous prostaglandins include ﬁve major bioactive com-
pounds: prostaglandin E2 (PGE2), prostaglandin F2α (PGF2α), 
prostaglandin D2 (PGD2), prostacyclin (PGI2), and thromboxane 
A2 (TXA2). Each compound exerts its biological eﬀects via speciﬁc 
G protein–coupled receptors. PGE2, the major prostanoid synthe-
sized in kidney and vasculature, is unique in that it can activate 
four distinct receptors—designated E-prostanoid receptor 1 (EP1), 
EP2, EP3, and EP4—encoded by diﬀerent genes. These receptors 
can be selectively activated by diﬀerent structural PGE2 analogs. 
Intravenous infusion of PGE2 reduces blood pressure, but disrup-
tion of the EP2 receptor unmasks a pressor response to PGE2, sug-
gesting a depressor role for the EP2 receptor. Because angiotensin 
II stimulates PGE2 synthesis, endogenous PGE2 could modulate 
angiotensin’s action in either a pressor or a depressor fashion.
To elucidate the role of PGE2 EP1 receptor in blood pressure 
regulation, Guan et al. used an EP1 receptor antagonist and found 
that it reduced blood pressure in spontaneously hypertensive rats. 
To establish that this antihypertensive eﬀect was caused by EP1-
receptor inhibition, they generated an EP1-null mouse. These mice 
had a blunted acute pressor response to angiotensin II and less 
angiotensin II–mediated hypertension. The EP1-receptor antago-
nist blunted the constricting eﬀect of angiotensin II in perfused 
preglomerular renal arterioles and mesenteric arteriolar rings. 
These results contribute to our understanding of prostaglandins’ 
role in regulating blood pressure and suggest that the EP1 receptor 
could be a target for antihypertensive therapy. (J Clin Invest 2007; 
117: 2496–2505)
Juan Oliver
Systemic vascular pathologies in VEGFECKO mice (endothelial cells 
with deletion of VEGF). H&E, hematoxylin and eosin. PECAM, platelet 
endothelial cell adhesion molecule.
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